NYSE:RAL Ralliant (RAL) Stock Price, News & Analysis $58.67 -0.17 (-0.28%) Closing price 03:59 PM EasternExtended Trading$58.40 -0.27 (-0.47%) As of 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Ralliant Stock (NYSE:RAL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Ralliant alerts:Sign Up Key Stats Today's Range$56.85▼$59.4450-Day Range$39.46▼$61.4152-Week Range$37.27▼$62.35Volume2.25 million shsAverage Volume1.84 million shsMarket Capitalization$6.57 billionP/E RatioN/ADividend Yield0.34%Price Target$61.90Consensus RatingModerate Buy Company Overview Ralliant, Inc. (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure. The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians. These systems integrate tissue digestion, cell separation and cryogenic storage in a closed-system format, helping to maintain cell viability and sterility throughout the procedure. Ralliant’s offerings are designed to meet regulatory requirements and support a variety of clinical protocols. Ralliant’s technologies are applied in orthopedic, aesthetic and wound-healing settings, where practitioners leverage the regenerative properties of SVF cells to support tissue repair and remodeling. By providing turnkey solutions for adipose-derived cell therapies, the company aims to expand the adoption of minimally invasive, autologous treatments and accelerate the translation of regenerative medicine research into routine clinical practice. Headquartered in the United States, Ralliant distributes its systems through a combination of direct sales and strategic partnerships across North America, Europe and select international markets. The company’s leadership team combines expertise in medical device engineering, clinical research and commercial operations, positioning Ralliant to address evolving needs in cell-based therapy and point-of-care processing.AI Generated. May Contain Errors. Read More Ralliant Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks40th Percentile Overall ScoreRAL MarketRank™: Ralliant scored higher than 40% of companies evaluated by MarketBeat, and ranked 54th out of 80 stocks in the manufacturing sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.7 / 5Analyst RatingModerate Buy Consensus RatingRalliant has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 7 buy ratings, 4 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Ralliant is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageRalliant has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Ralliant's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth13.69% Earnings GrowthEarnings for Ralliant are expected to grow by 13.69% in the coming year, from $2.63 to $2.99 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ralliant is -5.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Ralliant is -5.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioRalliant has a PEG Ratio of 2.68. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioRalliant has a P/B Ratio of 4.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.39% of the float of Ralliant has been sold short.Short Interest Ratio / Days to CoverRalliant has a short interest ratio ("days to cover") of 5.9.Change versus previous monthShort interest in Ralliant has recently increased by 22.81%, indicating that investor sentiment is decreasing significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldRalliant has a dividend yield of 0.34%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthRalliant does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Ralliant will have a dividend payout ratio of 6.69% next year. This indicates that Ralliant will be able to sustain or increase its dividend.Read more about Ralliant's dividend. News and Social Media2.8 / 5News Sentiment0.44 News SentimentRalliant has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Manufacturing companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Ralliant this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for RAL on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added Ralliant to their MarketBeat watchlist in the last 30 days. Company Ownership0.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Ralliant insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $364,470.00 in company stock.Percentage Held by InstitutionsRalliant has minimal institutional ownership at this time.Read more about Ralliant's insider trading history. Receive RAL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ralliant and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RAL Stock News HeadlinesRalliant Corporation (RAL) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference TranscriptMay 18 at 6:30 PM | seekingalpha.comRalliant Spotlights Award of $27.3M Investment from the Defense Production Act to Scale Production at its PacSci EMC Operating CompanyMay 18 at 8:35 AM | businesswire.comI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.May 19 at 1:00 AM | Brownstone Research (Ad)Ralliant’s Earnings Beat Refines Outlook Productivity Goals And Capital ReturnsMay 17 at 7:53 AM | finance.yahoo.comRalliant to Present at Upcoming Investor ConferencesMay 15, 2026 | businesswire.comRalliant Corporation (RAL) Gets a Buy from Truist FinancialMay 15, 2026 | theglobeandmail.comRalliant's (RAL) Buy Rating Reaffirmed at Truist FinancialMay 14, 2026 | americanbankingnews.comRalliant Analysts Raise Their Forecasts After Better-Than-Expected Q1 EarningsMay 13, 2026 | benzinga.comSee More Headlines RAL Stock Analysis - Frequently Asked Questions How have RAL shares performed this year? Ralliant's stock was trading at $50.99 at the beginning of the year. Since then, RAL stock has increased by 15.1% and is now trading at $58.6730. How were Ralliant's earnings last quarter? Ralliant Corporation (NYSE:RAL) posted its quarterly earnings data on Tuesday, May, 12th. The company reported $0.57 earnings per share for the quarter, beating analysts' consensus estimates of $0.49 by $0.08. The business's revenue was up 11.0% on a year-over-year basis. Read the conference call transcript. Who are Ralliant's major shareholders? Top institutional shareholders of Ralliant include Irenic Capital Management LP (1.55%), Arrowstreet Capital Limited Partnership (1.31%), Dimensional Fund Advisors LP (1.17%) and Rokos Capital Management LLP (0.90%). Insiders that own company stock include Karen M Bick, Amir A Kazmi, Kate Mitchell, Anelise Angelino Sacks and Kevin E Bryant. View institutional ownership trends. How do I buy shares of Ralliant? Shares of RAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Record date for 3/23 Dividend3/09/2026Ex-Dividend for 3/23 Dividend3/09/2026Dividend Payable3/23/2026Last Earnings5/12/2026Today5/19/2026TD Cowen's 54th Annual Technology, Media & Telecom Conference5/28/2026Record date for 6/23 Dividend6/08/2026Ex-Dividend for 6/23 Dividend6/08/2026Dividend Payable6/23/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorManufacturing Industry Industrial Measurement Instruments & Related Products Sub-IndustryMeasuring And Control Equipment Current SymbolNYSE:RAL Previous SymbolNYSE:RAL CIK2041385 Webwww.ralliant.com Phone(425) 446-5000FaxN/AEmployees7,000Year FoundedN/APrice Target and Rating Average Price Target for Ralliant$61.90 High Price Target$70.00 Low Price Target$45.00 Potential Upside/Downside+5.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($10.94) Trailing P/E RatioN/A Forward P/E Ratio22.31 P/E Growth2.65Net Income-$1.22 billion Net Margins-58.55% Pretax Margin-58.30% Return on Equity12.49% Return on Assets6.40% Debt Debt-to-Equity Ratio0.73 Current Ratio1.61 Quick Ratio1.05 Sales & Book Value Annual Sales$2.07 billion Price / Sales3.17 Cash Flow$16.48 per share Price / Cash Flow3.56 Book Value$13.99 per share Price / Book4.19Miscellaneous Outstanding Shares111,930,000Free FloatN/AMarket Cap$6.57 billion OptionableN/A BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:RAL) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ralliant Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Ralliant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.